Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC

62
The B.C. Children’s Hospital pharmacy is used for research studies.
BRITISH COLUMBIA
Prior to initiation of a trial at the facility, it must be presented at a monthly Research Meeting for approval.
Researchers work together with the Research Manager to develop trial specific procedures that
are in line with the guidelines for conducting research in this vulnerable population that have been set
out by the Program.
To ensure Quality Control and Assurance, the facility and its investigators follow Tri-Council (CIHR,
NSERC, SSHERC) and ICH-GCP guidelines. Furthermore, the Program has extensive standard guidelines
for all research within the NICU, which focuses specifically on the fact that the research involves
a vulnerable population. All new research staff are trained in Tri-council, ICH-GCP, and Neonatal Program
guidelines. Each study maintains a specific procedure manual that conforms with these research
standards and outlines the specific requirements of that study. Finally, annual audits are performed to
ensure study files are appropriate and up to date, and that research standards (regarding guidelines,
defined study-specific procedures, SOPs, REB renewal, etc.) are being met.
Contact:
Claydon, Jennifer. Research Program Manager. Tel: 604-875-2000 x 7408. jclaydon@cw.bc.ca.
Neurosciences Program
Clinical trials investigators within the Neurosciences Program are focused on drug therapies and technology
assessments for neurological conditions such as epilepsy and neuromuscular disease (www.
bcchildrens.ca/Services/Neurosciences/ProgramsServices.htm).
Contact:
Farrell, Kevin, Clinical Neurologist. Tel: 604-875-2976. kfarrell@cw.bc.ca.
Pediatric Anesthesia Department
The Pediatric Anesthesia Department cares for children of all ages with many different medical conditions
(www.bcchildrens.ca/Services/SurgeryAndSurgSuites/AnesthesiaService/default.htm). It provides
sedation and anesthesia for a wide range of surgical and diagnostic procedures, as well as pain management.
A major research focus is on the use of new technology, and the information derived from
such advances, to reduce patient risk in anesthesia and intensive care (see www.cfri.ca/our_research/
researchers/search_researchers/researcher_detail.asp?ID=3).
Contact:
Ansermino, Mark. Director of Research. Tel: 604-875-2711. anserminos@yahoo.ca.
Pediatric Oncology/ BMT/ Hematology
BCCH is a major centre for pediatric oncology and hematology studies. Headed by Dr. Paul Rogers,
the Pediatric Oncology/BMT /Hematology Program (www.kidscancer.bc.ca) conducts Phase III clinical
trials and has almost 50 North America-wide protocols a year approved under the Children’s Oncology
Group. The team works in close collaboration with the B.C. Cancer Agency in providing treatment and
follow-up for children with cancer.